The ETF's investment objectives are to provide holders, through an actively managed portfolio, with (i) regular cash distributions, (ii) the opportunity for capital appreciation by investing on an equal weight basis in a portfolio of securities of the 20 health care companies (as determined by the Manager in its discretion) with the largest market capitalization listed on a North American stock exchange, and (iii) lower overall volatility of returns on the portfolio than would be experienced by owning a portfolio of securities of such issuers directly, by employing a covered call option writing program. The foreign currency exposure attributable to the Units will not be hedged back to the Canadian dollar.
Investor suitability
For those who:
| 1m | 3m | 6m | YTD | 1y | 2y | SI | |
|---|---|---|---|---|---|---|---|
| FHI.B | 0.45% | 2.75% | 5.92% | 6.64% | 6.64% | 9.07% | 10.62% |
| Benchmark | 2.15% | 3.03% | 6.98% | 11.46% | 11.46% | 13.06% | 39.48% |
| As at: 31 Dec 2020 - Benchmark: S&P 500 Health Care Index (Unhedged) | |||||||
As at December 31, 2020
The indicated rates of return are the historical annual compounded total returns, including changes in unit value and do not take into account sales, redemption or optional charges or income taxes payable by a security holder that would have reduced returns.
S&P 500 Health Care Index is a market capitalization weighted index. The constituents of the Index are a subset of the constituents of the S&P 500 Index that have been classified as part of the health care sector according to the Global Industry Classification Standard.
Fund Characteristics | |
| Gross Option Premium* | 6.71% |
|---|---|
| Current Dividend Yield1 | 2.01% |
| Price/Earnings Ratio | 25.05 |
| Price/Book Ratio | 3.94 |
| As at 31 Dec, 2020 * Gross Option Premiums represent those received on 18 Dec, 2020 1 The Current Dividend Yield represents the gross yield on the ETF`s underlying portfolio of securities. It is not the yield or the distribution investors will receive by virtue of an investment in the ETF. | |
Fund Statistics | |
| P/S Ratio (TTM) (Long) | 1.81 |
|---|---|
| P/C Ratio (TTM) (Long) | 12.89 |
| ROA % (TTM) (Long) | 6.79 |
| ROE % (TTM) (Long) | 25.76 |
| As at 31 Dec, 2020 | |
Number of securities: 40
| Security Type | % |
|---|---|
| Foreign Stock | 97.78% |
| Currency Security | 2.22% |
| Name | Security Type | ISIN | Ticker | % |
|---|---|---|---|---|
| CIGNA CORP | Foreign Stock | US1255231003 | CI US | 5.35 |
| ELI LILLY AND CO | Foreign Stock | US5324571083 | LLY US | 5.24 |
| CVS HEALTH CORP | Foreign Stock | US1266501006 | CVS US | 5.16 |
| THERMO FISHER SCIENTIFIC INC | Foreign Stock | US8835561023 | TMO US | 5.11 |
| GILEAD SCIENCES INC | Foreign Stock | US3755581036 | GILD US | 5.05 |
| ABBVIE INC | Foreign Stock | US00287Y1091 | ABBV US | 5.05 |
| AMGEN INC | Foreign Stock | US0311621009 | AMGN US | 5.04 |
| DANAHER CORP | Foreign Stock | US2358511028 | DHR US | 5.04 |
| BRISTOL-MYERS SQUIBB CO | Foreign Stock | US1101221083 | BMY US | 5.01 |
| JOHNSON & JOHNSON | Foreign Stock | US4781601046 | JNJ US | 4.99 |
| ANTHEM INC | Foreign Stock | US0367521038 | ANTM US | 4.97 |
| MERCK & CO INC | Foreign Stock | US58933Y1055 | MRK US | 4.96 |
| UNITEDHEALTH GROUP INC | Foreign Stock | US91324P1021 | UNH US | 4.95 |
| BECTON DICKINSON AND CO | Foreign Stock | US0758871091 | BDX US | 4.93 |
| HCA HEALTHCARE INC | Foreign Stock | US40412C1018 | HCA US | 4.86 |
| STRYKER CORP | Foreign Stock | US8636671013 | SYK US | 4.85 |
| ABBOTT LABORATORIES | Foreign Stock | US0028241000 | ABT US | 4.82 |
| MEDTRONIC PLC | Foreign Stock | IE00BTN1Y115 | MDT US | 4.82 |
| ZOETIS INC | Foreign Stock | US98978V1035 | ZTS US | 4.72 |
| PFIZER INC | Foreign Stock | US7170811035 | PFE US | 4.64 |
| PFE US CALL 38 01/15/21 PFIZER INC (16/01/2021) | Option | 0.00 | ||
| ZTS US CALL 165 01/15/21 ZOETIS INC (16/01/2021) | Option | 0.00 | ||
| ABBV US CALL 105 01/15/21 ABBVIE INC (16/01/2021) | Option | 0.00 | ||
| MDT US CALL 120 01/15/21 MEDTRONIC PLC (16/01/2021) | Option | 0.00 | ||
| ABT US CALL 110 01/15/21 ABBOTT LABORATORIES (16/01/2021) | Option | 0.00 | ||
| SYK US CALL 240 01/15/21 STRYKER CORP (16/01/2021) | Option | 0.00 | ||
| HCA US CALL 165 01/15/21 HCA HOLDINGS INC (16/01/2021) | Option | 0.00 | ||
| MRK US CALL 80 01/15/21 MERCK & CO INC (16/01/2021) | Option | 0.00 | ||
| DHR US CALL 230 01/15/21 DANAHER CORP (16/01/2021) | Option | 0.00 | ||
| BDX US CALL 250 01/15/21 BECTON DICKINSON AND CO (16/01/2021) | Option | 0.00 | ||
| UNH US CALL 340 01/15/21 UNITEDHEALTH GROUP INC (16/01/2021) | Option | 0.00 | ||
| JNJ US CALL 155 01/15/21 JOHNSON & JOHNSON (16/01/2021) | Option | 0.00 | ||
| ANTM US CALL 310 01/15/21 ANTHEM INC CLL (16/01/2021) | Option | 0.00 | ||
| GILD US CALL 60 01/15/21 GILEAD SCIENCES INC COM (16/01/2021) | Option | 0.00 | ||
| AMGN US CALL 230 01/15/21 AMGEN INC (16/01/2021) | Option | 0.00 | ||
| BMY US CALL 62.5 01/15/21 BRISTOL-MYERS SQUIBB CO (16/01/2021) | Option | 0.00 | ||
| CVS US CALL 70 01/15/21 CVS CAREMARK CORP (16/01/2021) | Option | 0.00 | ||
| TMO US CALL 460 01/15/21 THERMO FISHER SCIENTIFIC (16/01/2021) | Option | 0.00 | ||
| LLY US CALL 170 01/15/21 ELI LILLY & CO (16/01/2021) | Option | 0.00 | ||
| CI US CALL 200 01/15/21 CIGNA CORPORATION COM (16/01/2021) | Option | 0.00 | ||
| Currency Security | 2.26 | |||
As at: 14 January 2021 | 101.82% | |||
Twelve month trailing distribution yield : 9.30% (as at 14 Jan 2021)
| FHI.B | Total | Cash | Reinvested | Eligible dividends | Non eligible dividends | Other income | Capital Gains | Return of capital | Foreign Income | Foreign tax paid |
|---|---|---|---|---|---|---|---|---|---|---|
| SI | $1.87130 | $1.87130 | - | - | - | - | $0.20669 | $0.48426 | $0.17135 | $0.02570 |
| 2020 + | $1.03470 | $1.03470 | - | - | - | - | - | - | - | - |
| 23-Dec | $0.29290 | $0.29290 | - | - | - | - | - | - | - | - |
| 24-Sep | $0.28130 | $0.28130 | - | - | - | - | - | - | - | - |
| 24-Jun | $0.29900 | $0.29900 | - | - | - | - | - | - | - | - |
| 25-Mar | $0.16150 | $0.16150 | - | - | - | - | - | - | - | - |
| 2019 + | $0.60530 | $0.60530 | - | - | - | - | - | $0.45965 | $0.17135 | $0.02570 |
| 23-Dec | $0.12960 | $0.12960 | - | - | - | - | - | $0.09842 | $0.03669 | $0.00550 |
| 24-Sep | $0.15350 | $0.15350 | - | - | - | - | - | $0.11656 | $0.04345 | $0.00652 |
| 24-Jun | $0.15350 | $0.15350 | - | - | - | - | - | $0.11656 | $0.04345 | $0.00652 |
| 25-Mar | $0.16870 | $0.16870 | - | - | - | - | - | $0.12811 | $0.04776 | $0.00716 |
| 2018 + | $0.23130 | $0.23130 | - | - | - | - | $0.20669 | $0.02461 | - | - |
| 21-Dec | $0.11570 | $0.11570 | - | - | - | - | $0.10339 | $0.01231 | - | - |
| 24-Sep | $0.11560 | $0.11560 | - | - | - | - | $0.10330 | $0.01230 | - | - |
(1) Future distribution dates may be amended at any time. (2) Reinvested distributions are not paid in cash but instead remain invested in the Fund. To recognize that these distributions have been allocated to investors for tax purposes the amounts of these distributions should be added to the adjusted cost base of the units held. (3) The characterization of distributions for tax purposes (such as dividends/other income/capital gains etc.) will not be known for certain until after the Fund's tax year end. Therefore investors will be informed of the characterization of the amounts distributed for tax purposes only for the entire year and not with each distribution. For tax purposes these amounts will be reported by brokers on official tax statements.
30 Jun, 2020 - Semi-Annual Financial Statements
31 Dec, 2019 - Annual Financial Statements
30 Jun, 2020 - Management Report of Fund Performance
31 Dec, 2019 - Annual Management Report of Fund Performance
30 Sep, 2020 - Summary of Investment Portfolio
31 Mar, 2020 - Summary of Investment Portfolio
National Instrument 81-106 Investment Fund Continuous Disclosure requires disclosure of the proxy voting record on an annual basis for the period ending on June 30 of each year. The proxy voting record must be posted on the website no later than August 31 of each year.
Canadian securities law provides that the manager of an investment funds (in this case, CI Investments Inc. ("CI")), acting on behalf of the investment fund, has the right and obligation to vote proxies relating to the investment fund's portfolio securities. As a practical matter, CI delegates this function to the applicable portfolio manager or sub-adviser, as part of the portfolio manager's or sub-adviser's general management of the investment fund assets, subject to oversight by CI. CI generally requires that applicable portfolio managers or sub-advisers vote all proxies in the best interest of CI's funds and their securityholders, as determined solely by the portfolio manager or sub-adviser, and subject to CI's proxy voting policy, the guidelines applicable to the individual portfolio manager or sub-adviser, and applicable legislation. Portfolio managers and sub-advisers are generally expected to vote on any matter for which the investment fund receives proxy materials for a meeting of securityholders of an issuer.
Proxy voting record for the most recent year:
30 Jun, 2020 - Proxy Voting Record
Warning: Documents posted on this website (including, without limitation, prospectuses) are current only as of the date on them
To access the SEDAR filings of CI First Asset Health Care Giants Covered Call ETF (Unhedged) please click here| CI Covered Call ETFs - Strategy Overview | Nov 6, 2020 | Positioning Piece |  |
